These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8362504)

  • 1. Clinical, biochemical, and hematologic evaluation of normal dogs after administration of rabbit anti-dog thymocyte serum.
    Mathews KA; Gallivan GJ; Mallard BA
    Vet Surg; 1993; 22(3):213-20. PubMed ID: 8362504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
    Valladares JE; Alberola J; Esteban M; Arboix M
    Vet Rec; 1996 Feb; 138(8):181-3. PubMed ID: 8677619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal allograft survival in outbred mongrel dogs using rabbit anti-dog thymocyte serum in combination with immunosuppressive drug therapy with or without donor bone marrow.
    Mathews KA; Holmberg DL; Johnston K; Miller CM; Binnington AG; Maxie G; Atilola M; Smith G
    Vet Surg; 1994; 23(5):347-57. PubMed ID: 7839592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-thymocyte serum as part of an immunosuppressive regimen in treating haematological immune-mediated diseases in dogs.
    Cuq B; Blois SL; Mathews KA
    J Small Anim Pract; 2017 Jun; 58(6):348-354. PubMed ID: 28369956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and dosing regimen of aminosidine in the dog.
    Belloli C; Crescenzo G; Carli S; Villa R; Sonzogni O; Carelli G; Ormas P
    Vet Res Commun; 1996; 20(6):533-41. PubMed ID: 8950834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog.
    Tassi P; Ormas P; Madonna M; Carli S; Belloli C; De Natale G; Ceci L; Marcotrigiano GO
    Res Vet Sci; 1994 Mar; 56(2):144-50. PubMed ID: 8191002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
    Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
    J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration.
    Collste LG
    Acta Chir Scand; 1972; 138(7):661-6. PubMed ID: 4566004
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.
    Rebuelto M; Albarellos G; Ambros L; Kreil V; Montoya L; Bonafine R; Otero P; Hallu R
    J Vet Pharmacol Ther; 2002 Feb; 25(1):73-6. PubMed ID: 11874531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lymphocytic globulin in canine renal allotransplantation. I. Histologic and immunohistologic findings for two preparations given by subcutaneous and intravenous routes.
    Collste LG; Wasserman J; Bergstrand A; Groth CG
    Acta Chir Scand; 1972; 138(7):655-60. PubMed ID: 4566003
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and clinical efficacy of cefotaxime for the treatment of septicaemia in dogs.
    Sumano H; Gutierrez L; Ocampo L
    Acta Vet Hung; 2004; 52(1):85-95. PubMed ID: 15119790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
    Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
    J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone treatment alters the serum amylase and lipase activities in normal dogs without causing pancreatitis.
    Fittschen C; Bellamy JE
    Can J Comp Med; 1984 Apr; 48(2):136-40. PubMed ID: 6202383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs.
    Landoni MF; Albarellos GA
    J Vet Pharmacol Ther; 2019 Mar; 42(2):171-178. PubMed ID: 30302775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine-induced emesis in the dog--routes of administration, efficacy and synergism by naloxone.
    Scherkl R; Hashem A; Frey HH
    J Vet Pharmacol Ther; 1990 Jun; 13(2):154-8. PubMed ID: 2384906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of antilymphocyte globulin.
    Najarian JS; Simmons RL
    N Engl J Med; 1971 Jul; 285(3):158-66. PubMed ID: 4103453
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunct antilymphocyte globulin therapy in canine renal allograft recipients: importance of preoperative administration.
    Kelly GE; Drummond M; Sheil AG
    J Surg Res; 1974 Jun; 16(6):620-3. PubMed ID: 4599465
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors involved in the choice of routes of administration of antimicrobial drugs.
    Baggot JD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1076-82. PubMed ID: 6392233
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of cefotaxime in the dog.
    Guerrini VH; English PB; Filippich LJ; Schneider J; Bourne DW
    Vet Rec; 1986 Jul; 119(4):81-3. PubMed ID: 3750783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.